The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.

Diabetes mellitus is a metabolic disorder characterized by altered glucose tolerance and impaired lipid and carbohydrate metabolism, and is associated with a number of complications directly resulting from hyperglycemiainduced inflammation.

Mayo Clinic researchers helped clarify a growing concern about the link between diabetes mellitus treatments and heart attack with the first large, population-based study showing that a group of common medications does not reduce diabetic patients’ heart attack survival rates.

Diabetic patients with NAFLD are at risk for progressive liver disease. In this study, researchers examined connections between white adipose tissue in the abdomen and medical disorders including insulin resistance (IR, inadequate response to insulin) and diabetes mellitus in patients with obesity and NAFLD to evaluate whether cell signaling pathway profiles within WAT are associated with the presence of IR and whether they can predict the resolution of DM after weight loss.

From Bombay to Beijing, a newly affluent Asian middle class is increasingly adapting Western lifestyles. Many city dwellers opt for high calorie fast food instead of healthier traditional meals and are becoming less and less physically active. This comes with a price: diabetes, mainly caused by excess weight and lack of exercise, has reached epidemic levels in Asia.